Remove 2021 Remove Medicare Remove Prescription Drug Pricing
article thumbnail

Magnolia Regional used price transparency IT to get more CHF patients to fill their prescriptions

Healthcare It News

"Next, we used MedHx to gather complete patient medication history so we could track whether patients in the study had filled their prescriptions," he added. From July 2020 to September 2021, Magnolia Regional studied medication adherence and prescription fill rates for 417 patients with CHF. ADVICE FOR OTHERS.

article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

County-level variation in cardioprotective antihyperglycemic prescribing among medicare beneficiaries. Reforming Patient Cost Sharing for Cancer Medications in Medicare Part D. New Reforms to Prescription Drug Pricing in the US: Opportunities and Challenges. Am J Prev Cardiol. 2022 Aug 2;11:100370. Lancet Oncol.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Comments to CMS Guidance on the Medicare Prescription Drug Inflation Rebate Program Due March 11, 2023

Health Law Advisor

To advance these efforts, CMS established a Medicare Drug Rebate and Negotiations Group dedicated to the IRA and set forth the agency’s intended overarching timeline to implement the various IRA provisions, such as the Medicare Drug Price Negotiation Program and the Part D redesign.

article thumbnail

Support for Drug Price Negotiation Brings Partisans Together in the U.S.

Health Populi

Drug price negotiation, say by the Medicare program, is a unifying public policy in the current era of political schisms in America, based on the findings in a special Kaiser Family Foundation (KFF) Health Tracking Poll conducted in late September-early October 2021.

article thumbnail

New York Enacts Landmark Legislation Regulating PBMs

Health Care Law Brief

On December 31, 2021, New York Governor Kathy Hochul signed landmark legislation to increase the transparency of prescription drug pricing and to establish requirements on pharmacy middlemen. Disclosure requirements.

article thumbnail

What’s Expected to Drive Up Health Plan Costs in 2025: GLP-1s, Behavioral Health, and Inflationary Pressures for Hospitals and Doctors – PwC’s Behind the Numbers 2025

Jane Sarashon

This graph diagrams utilization, unit cost, and cost as a percent of overall medical cost trend: note that by the middle of 2023, GLP-1 drug costs for Group health plan members comprised 13.6% in 2021 to 7.3 in 2021 rising to $23.16 of a major pharmacy benefit management (PBM) company, shown in the third bar.

Doctors 59
article thumbnail

Gallup Reveals Americans’ Views on Industry Are the Lowest Since 2008 – Implications for Healthcare and Pharma

Jane Sarashon

The year-on-year decline from 2021 find oil and gas at the lowest level of positivity, advertising/PR, legal, the Federal government, and pharma at the bottom of the ratings. Which sectors enhanced consumers’ favorable views between 2021 and 2022?